January 31, 2017

The MHSRS is the Department of Defense's (DoD) premier scientific meeting. This Joint symposium provides a collaborative environment for military medical care providers with deployment experience, DoD scientists, academia, and industry to exchange information on research advancements and health care developments in the areas of Combat Casualty Care, Military Operational Medicine, Clinical and Rehabilitative Medicine, and Military Infectious Disease Research Programs. It is the only scientific meeting that addresses the unique medical needs of the Warfighter.

November 16, 2016

As part of the FDA’s ongoing effort to ensure patients and providers have timely and continued access to safe, effective, and high-quality medical devices, the FDA

February 25, 2016

The Food and Drug Administration (FDA), in co-sponsorship with the Foundation for the National Institutes of Health Biomarkers Consortium (FNIH BC), is announcing a public workshop entitled “Developing an Evidentiary Standards Framework for Safety Biomarkers Qualification Workshop.” The purpose of the workshop is to discuss the evidentiary standards needed to support biomarker qualification with a particular emphasis on drug safety markers.

February 10, 2016

This public workshop aims to examine potential biomarkers, discuss the challenges and solutions related to biomarker development methodologies, and establish strategies for data standardization, sharing and analysis of big data sets for Traumatic Brain Injury (TBI). By convening the relevant stakeholders, the goal is to obtain input on the scientific, clinical, patient and regulatory considerations associated with TBI biomarker development to improve diagnosis and clinical utility for TBI.